Nature Neuroscience issues correction to competing interests statement on endocannabinoid reward study
The journal has published an author correction to a study on endocannabinoids and reward engagement, updating the competing interests disclosure. The revised statement discloses that several authors are co-founders, board members, or the CEO of Biosyft, LLC, a company developing technologies related to the paper's subject matter. The correction applies to both the HTML and PDF versions of the article.